1
/
of
1
Elabscience
SKU:PKSR030466
Recombinant 2019-nCoV Helicase Protein (His Tag)
Recombinant 2019-nCoV Helicase Protein (His Tag)
Regular price
$220.00 USD
Regular price
Sale price
$220.00 USD
Unit price
/
per
Shipping calculated at checkout.
Couldn't load pickup availability
Introducing the Recombinant 2019-nCoV Helicase Protein (His Tag), a highly purified and bioactive protein that is essential for the replication of the novel coronavirus. This protein is produced using advanced recombinant DNA technology and is expressed in a bacterial system, ensuring its high purity and quality. The protein is tagged with a histidine (His) tag, which allows for easy purification and detection.
The Recombinant 2019-nCoV Helicase Protein (His Tag) is a crucial component in the replication of the virus, making it an essential tool for research and development of antiviral drugs and vaccines. Its high purity and bioactivity make it an ideal candidate for use in biochemical assays, drug screening, and structural studies.
This product is supplied in a lyophilized form, ensuring its stability and long shelf life. It is available in various quantities to meet the needs of different research projects. The Recombinant 2019-nCoV Helicase Protein (His Tag) is a reliable and high-quality product that is essential for the study of the novel coronavirus and the development of effective treatments.
The Recombinant 2019-nCoV Helicase Protein (His Tag) is a crucial component in the replication of the virus, making it an essential tool for research and development of antiviral drugs and vaccines. Its high purity and bioactivity make it an ideal candidate for use in biochemical assays, drug screening, and structural studies.
This product is supplied in a lyophilized form, ensuring its stability and long shelf life. It is available in various quantities to meet the needs of different research projects. The Recombinant 2019-nCoV Helicase Protein (His Tag) is a reliable and high-quality product that is essential for the study of the novel coronavirus and the development of effective treatments.
Share
